Trials / Completed
CompletedNCT00257660
Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
A Phase III Multicentre, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Dysport® for the Treatment of Cervical Dystonia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 116 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to demonstrate the effectiveness and safety of 500 units of Dysport manufactured at a new manufacturing facility in Europe.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Botulinum toxin type A | 500 units |
| DRUG | Placebo | 500 units |
Timeline
- Start date
- 2005-10-10
- Primary completion
- 2006-09-01
- Completion
- 2006-09-01
- First posted
- 2005-11-23
- Last updated
- 2022-09-28
- Results posted
- 2010-05-10
Locations
22 sites across 2 countries: United States, Russia
Source: ClinicalTrials.gov record NCT00257660. Inclusion in this directory is not an endorsement.